Catalyst Wire Dossier Catalyst Wire Dossier

Rosiglitazone Extended Release Tablets

rosiglitazone · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Rosiglitazone Extended Release Tablets, covering 2013-01-14 to 2017-11-28. Get the full timeline:

Most recent: Clinical Trial Update: Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease [NA]

See pricing